145 related articles for article (PubMed ID: 30949129)
1. Sclerostin Antibody Mitigates Estrogen Deficiency-Inducted Marrow Lipid Accumulation Assessed by Proton MR Spectroscopy.
Li S; Huang B; Jiang B; Gu M; Yang X; Yin Y
Front Endocrinol (Lausanne); 2019; 10():159. PubMed ID: 30949129
[TBL] [Abstract][Full Text] [Related]
2. Effect of Leptin on Marrow Adiposity in Ovariectomized Rabbits Assessed by Proton Magnetic Resonance Spectroscopy.
Li S; Jiang H; Wang B; Gu M; Zhang N; Liang W; Wang Y
J Comput Assist Tomogr; 2018; 42(4):588-593. PubMed ID: 29489596
[TBL] [Abstract][Full Text] [Related]
3. Olive oil effectively mitigates ovariectomy-induced marrow adiposity assessed by MR spectroscopy in estrogen-deficient rabbits.
Liu Y; Tan H; Huang C; Li L; Wu S
Acta Radiol; 2022 Feb; 63(2):245-252. PubMed ID: 33497273
[TBL] [Abstract][Full Text] [Related]
4. Temporal changes in systemic and local expression of bone turnover markers during six months of sclerostin antibody administration to ovariectomized rats.
Stolina M; Dwyer D; Niu QT; Villasenor KS; Kurimoto P; Grisanti M; Han CY; Liu M; Li X; Ominsky MS; Ke HZ; Kostenuik PJ
Bone; 2014 Oct; 67():305-13. PubMed ID: 25093263
[TBL] [Abstract][Full Text] [Related]
5. Sclerostin vaccination mitigates estrogen deficiency induction of bone mass loss and microstructure deterioration.
Wang FS; Wu RW; Lain WS; Tsai TC; Chen YS; Sun YC; Ke HJ; Li JC; Hwang J; Ko JY
Bone; 2018 Jul; 112():24-34. PubMed ID: 29653294
[TBL] [Abstract][Full Text] [Related]
6. Sclerostin antibody prevented progressive bone loss in combined ovariectomized and concurrent functional disuse.
Zhang D; Hu M; Chu T; Lin L; Wang J; Li X; Ke HZ; Qin YX
Bone; 2016 Jun; 87():161-8. PubMed ID: 26868528
[TBL] [Abstract][Full Text] [Related]
7. Panax notoginseng saponins mitigate ovariectomy-induced bone loss and inhibit marrow adiposity in rats.
Fan JZ; Wang Y; Meng Y; Li GW; Chang SX; Nian H; Liang YJ
Menopause; 2015 Dec; 22(12):1343-50. PubMed ID: 26035148
[TBL] [Abstract][Full Text] [Related]
8. Proton Magnetic Resonance Spectroscopy-Detected Changes of Marrow Fat Content in a Rabbit Model of Osteoporosis Treated With Epigallocatechin-3-Gallate.
Liu Y; Wu S; Cui R; Chan Q; Zhang S; Liao Y; Huang C
J Comput Assist Tomogr; 2017; 41(2):231-235. PubMed ID: 27824667
[TBL] [Abstract][Full Text] [Related]
9. Influence of early zoledronic acid administration on bone marrow fat in ovariectomized rats.
Li GW; Xu Z; Chang SX; Zhou L; Wang XY; Nian H; Shi X
Endocrinology; 2014 Dec; 155(12):4731-8. PubMed ID: 25243855
[TBL] [Abstract][Full Text] [Related]
10. Icariin prevents ovariectomy-induced bone loss and lowers marrow adipogenesis.
Li GW; Xu Z; Chang SX; Nian H; Wang XY; Qin LD
Menopause; 2014 Sep; 21(9):1007-16. PubMed ID: 24552978
[TBL] [Abstract][Full Text] [Related]
11. Sclerostin Antibody Reverses Bone Loss by Increasing Bone Formation and Decreasing Bone Resorption in a Rat Model of Male Osteoporosis.
Li X; Ominsky MS; Villasenor KS; Niu QT; Asuncion FJ; Xia X; Grisanti M; Wronski TJ; Simonet WS; Ke HZ
Endocrinology; 2018 Jan; 159(1):260-271. PubMed ID: 29069393
[TBL] [Abstract][Full Text] [Related]
12. Effect of combined treatment with pulsed electromagnetic field stimulation and sclerostin monoclonal antibody on changes in bone metabolism and pedicle screw augmentation in rabbits with ovariectomy-induced osteoporosis.
Qian G; Wang M; Dong Y; Hong Y; Yu Y; Mei J
Ann Palliat Med; 2021 Feb; 10(2):1070-1078. PubMed ID: 33040558
[TBL] [Abstract][Full Text] [Related]
13. Oxytocin treatment prevents marrow adiposity observed in alloxan-induced diabetic rabbits using proton MR spectroscopy.
Lin H; Zheng M; Mao X; Feng X; Li J; Rao G; Lin F
Endokrynol Pol; 2018; 69(4):. PubMed ID: 29952410
[TBL] [Abstract][Full Text] [Related]
14. The beneficial effect of icaritin on osteoporotic bone is dependent on the treatment initiation timing in adult ovariectomized rats.
Peng S; Zhang G; Zhang BT; Guo B; He Y; Bakker AJ; Pan X; Zhen W; Hung L; Qin L; Leung WN
Bone; 2013 Jul; 55(1):230-40. PubMed ID: 23486180
[TBL] [Abstract][Full Text] [Related]
15. Marrow adiposity recovery after early zoledronic acid treatment of glucocorticoid-induced bone loss in rabbits assessed by magnetic resonance spectroscopy.
Li GW; Chang SX; Fan JZ; Tian YN; Xu Z; He YM
Bone; 2013 Feb; 52(2):668-75. PubMed ID: 23142803
[TBL] [Abstract][Full Text] [Related]
16. Sclerostin antibody treatment causes greater alveolar crest height and bone mass in an ovariectomized rat model of localized periodontitis.
Chen H; Xu X; Liu M; Zhang W; Ke HZ; Qin A; Tang T; Lu E
Bone; 2015 Jul; 76():141-8. PubMed ID: 25868799
[TBL] [Abstract][Full Text] [Related]
17. Retention of osteocytic micromorphology by sclerostin antibody in a concurrent ovariectomy and functional disuse model.
Zhang D; Miranda M; Li X; Han J; Sun Y; Rojas N; He S; Hu M; Lin L; Li X; Ke HZ; Qin YX
Ann N Y Acad Sci; 2019 Apr; 1442(1):91-103. PubMed ID: 30644553
[TBL] [Abstract][Full Text] [Related]
18. Effects of Total Flavonoids of Epimedium on Bone Marrow Adipose Tissue in Ovariectomized Rats.
Chen L; Ma R; Luo P; Shi D; Shi X; Nian H; Chang SX; Yuan W; Li GW
Front Endocrinol (Lausanne); 2022; 13():900816. PubMed ID: 35733771
[TBL] [Abstract][Full Text] [Related]
19. Effects of Sclerostin Antibody on the Healing of Femoral Fractures in Ovariectomised Rats.
Liu Y; Rui Y; Cheng TY; Huang S; Xu L; Meng F; Lee WY; Zhang T; Li N; Li C; Ke H; Li G
Calcif Tissue Int; 2016 Mar; 98(3):263-74. PubMed ID: 26603303
[TBL] [Abstract][Full Text] [Related]
20. Sclerostin antibody increases trabecular bone and bone mechanical properties by increasing osteoblast activity damaged by whole-body irradiation in mice.
Costa S; Fairfield H; Farrell M; Murphy CS; Soucy A; Vary C; Holdsworth G; Reagan MR
Bone; 2021 Jun; 147():115918. PubMed ID: 33737193
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
